Keyphrases
Immune Response
100%
Cystic Fibrosis
100%
Exhaled Breath
100%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Breath Profile
100%
Profile Changes
100%
Modulator Therapy
100%
Response to Therapy
60%
Volatile Organic Components
60%
Immune Reconstitution
40%
Non-responders
40%
Therapy Initiation
40%
Breath Volatiles
40%
Component Profiles
40%
Pediatric
20%
6-year-olds
20%
Whole Blood Stimulation
20%
Oxidative Stress
20%
Therapy Response
20%
Clinical Markers
20%
Airway Inflammation
20%
Prospective Longitudinal Study
20%
Sweat Chloride
20%
Pro-inflammatory Profile
20%
Proof of Concept Study
20%
Lumacaftor-ivacaftor
20%
Airway Pathogen
20%
INIS
therapy
100%
children
100%
fibrosis
100%
breath
100%
patients
25%
volatility
25%
inflammation
16%
blood
8%
stimulation
8%
pediatrics
8%
clearance
8%
defects
8%
oxidation
8%
pathogens
8%
chlorides
8%
sweat
8%
Medicine and Dentistry
Breathing
100%
Immune Response
100%
Cystic Fibrosis
100%
Volatile Organics
42%
Immune Reconstitution
28%
Oxidative Stress
14%
Pediatrics
14%
Treatment Response
14%
Pathogen
14%
Respiratory Tract Inflammation
14%
Sweat
14%
Patient with Cystic Fibrosis
14%
Ivacaftor
14%
Lumacaftor
14%